167 related articles for article (PubMed ID: 10342830)
1. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin.
Delbaere A; Sidis Y; Schneyer AL
Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830
[TBL] [Abstract][Full Text] [Related]
2. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
3. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1).
Wang QF; Khoury RH; Smith PC; McConnell DS; Padmanahban V; Midgley AR; Schneyer AL; Crowley WF; Sluss PM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1434-41. PubMed ID: 8636347
[TBL] [Abstract][Full Text] [Related]
4. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
[TBL] [Abstract][Full Text] [Related]
5. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells.
Di Simone N; Hall HA; Welt C; Schneyer AL
Endocrinology; 1998 Mar; 139(3):1147-55. PubMed ID: 9492049
[TBL] [Abstract][Full Text] [Related]
6. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
7. Activin-A regulates follistatin secretion from cultured rat anterior pituitary cells.
Bilezikjian LM; Corrigan AZ; Vaughan JM; Vale WM
Endocrinology; 1993 Dec; 133(6):2554-60. PubMed ID: 8243277
[TBL] [Abstract][Full Text] [Related]
8. [The regulation of gonadotropin receptor by the nonsteroidal intraovarian regulatory molecules during ovarian folliculogenesis].
Minegishi T
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug; 47(8):751-62. PubMed ID: 7594884
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of the gonadotropin-releasing hormone receptor gene by activin A.
Fernández-Vázquez G; Kaiser UB; Albarracin CT; Chin WW
Mol Endocrinol; 1996 Apr; 10(4):356-66. PubMed ID: 8721981
[TBL] [Abstract][Full Text] [Related]
10. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
Sidis Y; Tortoriello DV; Holmes WE; Pan Y; Keutmann HT; Schneyer AL
Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
[TBL] [Abstract][Full Text] [Related]
11. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
[TBL] [Abstract][Full Text] [Related]
12. Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.
Wang Q; Tabatabaei S; Planz B; Lin CW; Sluss PM
J Urol; 1999 Apr; 161(4):1378-84. PubMed ID: 10081911
[TBL] [Abstract][Full Text] [Related]
13. Regulation of follistatin production by rat granulosa cells in vitro.
Shintani Y; Dyson M; Drummond AE; Findlay JK
Endocrinology; 1997 Jun; 138(6):2544-51. PubMed ID: 9165047
[TBL] [Abstract][Full Text] [Related]
14. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
15. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
[TBL] [Abstract][Full Text] [Related]
16. Repression of glycoprotein hormone alpha-subunit gene expression and secretion by activin in alpha T3-1 cells.
Attardi B; Klatt B; Little G
Mol Endocrinol; 1995 Dec; 9(12):1737-49. PubMed ID: 8614410
[TBL] [Abstract][Full Text] [Related]
17. Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin.
Hashimoto O; Kawasaki N; Tsuchida K; Shimasaki S; Hayakawa T; Sugino H
Cell Signal; 2000 Aug; 12(8):565-71. PubMed ID: 11027950
[TBL] [Abstract][Full Text] [Related]
18. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
Wang QF; Tilly KI; Tilly JL; Preffer F; Schneyer AL; Crowley WF; Sluss PM
Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
[TBL] [Abstract][Full Text] [Related]
19. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
Dalkin AC; Haisenleder DJ; Yasin M; Gilrain JT; Marshall JC
Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
[TBL] [Abstract][Full Text] [Related]
20. Follistatin and its role as an activin-binding protein.
Sugino H; Sugino K; Hashimoto O; Shoji H; Nakamura T
J Med Invest; 1997 Aug; 44(1-2):1-14. PubMed ID: 9395712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
